Aromatase inhibitor use is a risk factor of carotid plaque presence in endocrine-responsive breast cancer patients

Background/Aims: The aromatase inhibitors (AIs) are well known anti-hormonal therapy in endocrine-responsive breast cancer patients. It can lead to dyslipidemia and be the risk factor of cardiovascular disease due to low estrogen level. However, some recent studies comparing AIs with placebo have sh...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Korean journal of internal medicine 2019-05, Vol.34 (3), p.579
Hauptverfasser:	Da Hea Seo, Yongin Cho, Sujin Lee, Seho Park, Seung-il Kim, Byeong Woo Park, Yumie Rhee
Format:	Artikel
Sprache:	kor
Schlagworte:	Aromatase inhibitors Breast neoplasms Cardiovascular diseases Carotid plaque Dyslipidemias
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!